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Abstract
Background: Interleukin-8 (IL-8, CXCL8) is a potent chemoattractant for neutrophils and contributes to acute liver
inflammation. Much less is known about IL-8 in chronic liver diseases (CLD), but elevated levels were reported from alcoholic
and hepatitis C-related CLD. We investigated the regulation of IL-8, its receptors CXCR1 and CXCR2 and possible IL-8
responding cells in CLD patients.
Methodology: Serum IL-8 levels were measured in CLD patients (n=200) and healthy controls (n=141). Intrahepatic IL-8,
CXCR1 and CXCR2 gene expression was quantified from liver samples (n=41), alongside immunohistochemical neutrophil
(MPO) and macrophage (CD68) stainings. CXCR1 and CXCR2 expression was analyzed on purified monocytes from patients
(n=111) and controls (n=31). In vitro analyses explored IL-8 secretion by different leukocyte subsets.
Principal Findings: IL-8 serum levels were significantly increased in CLD patients, especially in end-stage cirrhosis.
Interestingly, patients with cholestatic diseases exhibited highest IL-8 serum concentrations. IL-8 correlated with liver
function, inflammatory cytokines and non-invasive fibrosis markers. Intrahepatically, IL-8 and CXCR1 expression were
strongly up-regulated. However, intrahepatic IL-8 could only be associated to neutrophil infiltration in patients with primary
biliary cirrhosis (PBC). In non-cholestatic cirrhosis, increased IL-8 and CXCR1 levels were associated with hepatic macrophage
accumulation. In line, CXCR1, but not CXCR2 or CXCR3, expression was increased on circulating monocytes from cirrhotic
patients. Moreover, monocyte-derived macrophages from CLD patients, especially the non-classical CD16
+ subtype,
displayed enhanced IL-8 secretion in vitro.
Conclusions: IL-8 is strongly activated in CLD, thus likely contributing to hepatic inflammation. Our study suggests a novel
role of IL-8 for recruitment and activation of hepatic macrophages via CXCR1 in human liver cirrhosis.
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Introduction
Patients with chronic liver disease independent of its origin are
prone to develop liver fibrosis and cirrhosis resulting in potentially
lethal complications like esophageal varices or hepatic decompen-
sation [1]. Inflammation is a key factor in the initiation and
maintenance of fibrotic processes within the liver [2,3]. During
recent years, compelling evidence emerged that cellular compo-
nents of the innate immune system such as monocytes and NK
cells play major roles in perpetuating and modulating chronic liver
inflammation [4,5,6]. Neutrophils, another important cell popu-
lation of the innate immune response, have been intensively
studied in acute liver damage such as alcoholic hepatitis [7,8] or
ischemia-reperfusion injury [9]. Increased endotoxemia, observed
in patients with high ethanol intake, or ischemia-reperfusion lead
to neutrophil accumulation in hepatic sinusoids and post-
sinusoidal venules, resulting in extravasation and tissue infiltration.
Furthermore, the degree of neutrophil infiltration in alcoholic
hepatitis appears to be indicative of disease severity [10]. Yet, the
contribution of neutrophils to chronic liver damage is less clear.
For instance, it is controversial whether neutrophils are function-
ally intact or dysfunctional in patients with established cirrhosis
[11,12,13,14].
Apart from ‘classical’ inflammatory mediators like IL-1, TNFa
and LPS, CXC-motif chemokines are critically involved in
directing neutrophil trafficking towards sites of tissue injury [15].
IL-8 (CXCL8) is one important member of the CXC chemokine
family with an additional characteristic glutamate-leucine-arginine
(ELR) motif near the N-terminus of the molecule [16]. A key
function of these ELR
+ chemokines, such as CXCL8/IL-8, is the
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inflammation. Cytokines like IL-1 and TNFa are strong inducers
of ELR
+ chemokines [17]. IL-8 is synthesized by a vast number of
different cells. Virtually all cell subsets possessing toll-like-receptors
(TLR) are able to produce IL-8, among them monocytes and
macrophages [18,19]. CXCR1 and CXCR2 represent the cellular
targets of IL-8 [20]. While CXCR1 binds almost exclusively IL-8,
CXCR2 also shows high affinity to other CXC-chemokines (Gro-
a/b/c, NAP-2, ENA-78) [21]. Both, CXCR1 and CXCR2 can be
found on neutrophils, monocytes/macrophages and other leuko-
cyte subsets like T-cells [22,23].
Several observations suggested that IL-8 pathways might be also
involved in the pathogenesis of chronic liver disease. For instance,
IL-8 levels are increased intrahepatically and in the serum of
patients with alcoholic liver disease, probably contributing to
hepatic neutrophil accumulation and also exerting systemic actions
[24,25]. In patients with chronic hepatitis C, IL-8 serum levels are
associated with disease progression and relate to interferon
unresponsiveness [26]. Interestingly, experimental work raised
the possibility that IL-8 may not only act as a mere chemoat-
tractant protein in the liver, but also exerts direct profibrogenic
functions. As such, HCV core transduced Huh-7 cells were able to
stimulate hepatic stellate cells (HSC) in an IL-8 dependent manner
[27]. Likewise, IL-8 signalling has been linked to organ fibrosis in
the prostate gland, pancreas and lung [28,29,30].
In this study, we investigated whether the IL-8 pathway is
activated in patients with chronic liver disease (CLD). We
demonstrate that IL-8 is upregulated in the circulation as well as
in the liver of CLD patients, depending on disease severity and
etiology. Activation of IL-8 is linked to progression of liver fibrosis
in patients. Interestingly, monocytes/macrophages, and not
neutrophils, appear to be main responders to IL-8 in liver
fibrosis/cirrhosis via CXCR1. Moreover, the non-classical CD16
+
monocyte subset is also a potent producer of this chemokine in
humans.
Materials and Methods
Ethics Statement
Written informed consent was obtained from all participants.
The study protocol conformed to the ethical guidelines of the 1975
Declaration of Helsinki as reflected in a priori approval by the local
ethics committee of the University Hospital Aachen. The ethics
committee of the University Hospital Aachen, RWTH-University,
Aachen, Germany, specifically approved this study.
Patients and controls
We investigated CLD patients with or without liver cirrhosis [4].
The presence of liver cirrhosis was assessed according to various
imaging techniques (liver ultrasound, CT- or MRI-scan), biopsy or
laparoscopy findings and if typical complications of liver cirrhosis
(e.g. esophageal varices, ascites, hepatic encephalopathy) were
present in conjunction with the history of chronic liver disease
(Table 1). As controls, healthy volunteers with normal amino-
transferases and negative serology for HBV, HCV and HIV were
recruited from the local blood transfusion department.
In a subgroup of patients, liver tissue samples were available
from routine liver biopsies. Cirrhotic tissue was obtained from
explanted livers due to transplantation. Grading and staging of all
liver specimens was performed according to Desmet-Scheuer score
by a pathologist who was blinded for experimental data [4].
Normal liver samples were obtained from unaffected areas of liver
resections for secondary liver malignancy (mostly metastasis of
colorectal cancer).
IL-8 protein measurements
IL-8 protein in serum and cell culture supernatant was assessed
using the FlowCytomix System (eBioscience) according to
manufacturer’s instructions.
Purification of circulating CD14
+ monocytes
EDTA whole blood from patients and healthy controls was
directly subjected to peripheral blood mononuclear cell (PBMC)
purification by FICOLL density gradient (LSM-1077, PAA) as
previously described [31]. Monocytes were isolated by positive
selection with CD14 microbeads by MACS (Miltenyi Biotec). A
$95% purity of isolated monocytes was confirmed by flow-
cytometry using antibody staining for CD14, CD16, CD3, CD4,
CD8, CD19 and CD56 (BD). CXCR1 and CXCR2 staining was
performed by specific antibodies (R&D); staining protocols were
adapted from procedures previously established for different
chemokine receptors in our laboratory [32].
RNA isolation and gene expression analysis
RNA isolation from purified blood CD14
+ monocytes or snap
frozen whole liver tissue was conducted by pegGOLD (pegLAB).
Complementary cDNA was generated with 1 mg (blood mono-
cytes) and 2 mg RNA (liver specimen) by cDNA synthesis kit
(Roche). Real-time PCR was performed with SYBR green
(Invitrogen) in duplicates with b-actin as housekeeping gene
[33,34]. Primer sequences are available upon request.
Immunohistochemistry
Frozen liver sections were stained with polyclonal rabbit anti-
human MPO or monoclonal anti-human CD68 (Dako) by indirect
immunoperoxidase reaction in an autostainer system (Dako). Ten
visual-fields per slide were analysed at 2006 magnification by a
blinded investigator.
In vitro secretion of IL-8
Monocyte-derived macrophages were obtained as described
before, cultured in autologous serum and stimulated with 1 mg/ml
LPS for 24 h [31].
Analyses of macrophages derived from distinct monocyte
subpopulations were performed by pooling PBMC from three
buffy coats of healthy blood donors. For subsequent monocyte
subpopulation isolation either ‘‘monocyte-isolation-kit-II’’ or
‘‘CD16
+ monocytes-isolation-kit’’ (Miltenyi) were used for separa-
tion of CD14
+CD16
2 and CD14
+CD16
+ monocytes respectively
[4]. Isolation accuracy was confirmed by FACS analysis revealing
purities .90%. Lymphocytes were obtained after removal of
CD14
+ cells as a control population. 1610
6 cells/petri dish were
allowed to culture in RPMI medium containing 10% BSA and 1%
penicillin-streptomycin (PAA) for 5 days. IL-8 concentrations in
the supernatant were measured as described above.
Statistical analysis
Statistical comparisons between two groups were performed by
Mann-Whitney-U-test, multiple comparisons by ANOVA-test
followed by U-test for post hoc analysis using GraphPad Prism.
A p-value,0.05 was considered statistically significant. The levels
of significance are indicated in the figures as followed: *p,0.05;
**p,0.01; ***p,0.001. Data are depicted as bar graphs
representing mean and standard error of the mean (SEM).
Correlation analysis was performed by Spearman rank correlation
test (SPSS).
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Serum IL-8 levels are significantly elevated in chronic liver
disease, increase with stage of cirrhosis and vary
between different disease etiologies
To comprehensively address the general significance of IL-8 in
the progression of chronic liver diseases (CLD), IL-8 serum levels
were measured in a large cohort of patients (n=200) in
comparison to healthy volunteers (n=147). IL-8 serum concen-
trations were significantly increased in CLD patients compared to
controls (p,0.0001, Fig. 1A, Table 1). Of note, patients with
established liver cirrhosis displayed significantly higher IL-8 levels
than CLD patients without cirrhosis (p,0.0001, Fig. 1B). At all
stages of liver disease (no cirrhosis, Child A, B, C), patients
revealed significantly higher IL-8 concentrations than controls
(Fig. 1C). Highest IL-8 concentrations were found in patients with
decompensated, Child C-staged liver cirrhosis (Fig. 1C).
Interestingly, besides the clear association of IL-8 with disease
progression, there were striking variations in IL-8 serum levels
between the different etiologies of CLD. Patients with alcoholic,
but surprisingly also with cholestatic liver diseases were found to
have highest IL-8 serum concentrations (Fig. 1D), while patients
with viral hepatitis (hepatitis B or C) had much lower circulating
IL-8. These differences between the disease etiologies remained
significant, even if IL-8 levels were adjusted to the stage of
cirrhosis, which was achieved by the ratio of serum IL-8 and
Child-Pugh score points (Fig. 1E). In a small subgroup of patients
with PBC (n=8) we detected by far the highest serum levels of IL-
8. These findings were corroborated by correlations (Table 2)
between IL-8 serum levels and parameters indicating cholestasis
like total conjugated bilirubin (r=0.394, p,0.001), gamma-
glutamyl-transpeptidase (r=0.308, p,0.001) and alkaline phos-
phatase (r=0.402; p,0.001).
IL-8 had been functionally linked to hepatic neutrophil
infiltration, liver inflammation and to activation of profibrogenic,
collagen-producing hepatic stellate cells [10,27]. In fact, our
correlation analysis revealed that IL-8 levels were closely linked to
non-invasive markers of liver fibrosis (pro-collagen-III-peptide
r=0.349, p,0.001; hyaluronic acid r=0.314, p,0.001) and
inversely to markers of the hepatic biosynthetic capacity
(prothrombin time r=20.236, p=0.001; pseudocholinesterase
r=20.337, p,0.001). IL-8 did not correlate with alanine
aminotransferase activity (ALT), but with inflammatory cytokines
and chemokines (TNFa r=0.258, p,0.001; IL-6 r=0.340,
p,0.001; IP-10 [CXCL10] r=0.357, p,0.001; MIG [CXCL9]
r=0.340, p,0.001; IL-4 r=0.243, p=0.001). Noteworthy, the
counts of circulating neutrophils, that are targeted by IL-8, were
also correlated with this chemokine, although the correlation was
rather weak (absolute neutrophil count: r=0.163; p=0.004). In
line with this data, we detected a significant increase of neutrophils
in peripheral blood between non-cirrhotic and cirrhotic patients
(p=0.005), while neutrophil counts did not differ among the
various stages of liver cirrhosis (data not shown). These findings
showed that IL-8 is significantly elevated in CLD patients
dependent on disease etiology and severity, indicating that
increased circulating IL-8 may contribute to proinflammatory
and profibrogenic cascades during the progression of chronic liver
diseases.
IL-8 and its receptor CXCR1 are up-regulated
intrahepatically in chronic liver disease according to
fibrosis severity and underlying pathology
Based on previous findings that several parenchymal (injured
hepatocytes, biliary epithelial cells) and non-parenchymal (endo-
thelium) liver cells as well as infiltrating immune cells are the
primary sources of IL-8 in liver damage [27,35,36], we
hypothesized that the elevated circulating IL-8 in CLD patients
reflected increased hepatic IL-8 expression in liver disease. IL-8
gene expression was significantly up-regulated in diseased liver in
comparison to healthy control liver tissue by a mean of 12.4-fold
(Fig. 2A). Interestingly, hepatic IL-8 expression from CLD patients
exceeded by far conditions of acute liver failure (ALF), in which
Table 1. Characteristics of the study population.
all patients Stage of cirrhosis
no cirrh. Child A Child B Child C
n 200 75 45 37 43
sex male/female n 124/76 46/29 24/21 20/17 34/9
age median (range) yrs 53 (17–82) 43 (17–73) 62 (30–82) 59.5 (28–77) 53 (21–81)
disease etiology n
virus hepatitis 75 43 18 10 4
biliary/autoimmune 27 14 7 4 2
alcohol 60 5 13 14 28
other origin 38 13 7 9 9
MELD score median (range) n.a. n.a. 8 (6–17) 12 (7–21) 17 (9–28)
ALT median (range) U/L 46 (7–2103) 68 (10–2103) 41 (8–1247) 40.5 (7–437) 46 (11–261)
bilirubin median (range) mg/dl 1.3 (0.2–43.2) 0.7 (0.3–23.9) 0.9 (0.2–8.9) 2.05 (0.4–12.2) 4.7 (0.6–43.2)
albumin median (range) mg/dl 38 (12–61) 44.9 (29–61) 39 (28–49) 30.7 (12–43) 26 (12–60)
hyaluronic acid median (range) mg/l 190 (11–800) 31 (10–530) 240 (28–800) 500 (140–800) 740 (55–800)
procollagen-III-peptide median (range) mg/l 1160 (414–10400) 910 (414–1750) 1010 (456–3140) 1960 (639–10400) 2120 (696–6560)
IL-8 median (range) pg/ml 14 (14–1986) 15 (14–588) 28 (14–2530) 53 (14–1533) 88 (14–1533)
n.a., not applicable.
doi:10.1371/journal.pone.0021381.t001
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important mechanism of injury [15]. Highest IL-8 mRNA levels
were found in samples from cirrhotic livers (F4 fibrosis score),
while IL-8 induction at earlier fibrosis stages was more variable.
Among the different etiologies tested, patients with primary biliary
cirrhosis (PBC) exhibited highest IL-8 mRNA expression (Fig. 2A).
We next investigated the intrahepatic expression of IL-8
receptors CXCR1 and CXCR2 to analyze if hepatic IL-8 expression
drives activation or infiltration of responsive cells in CLD. In full
agreement with IL-8 expression, CXCR1 mRNA levels were
significantly increased in samples from CLD patients, especially in
advanced fibrosis/cirrhosis and in PBC patients (Fig. 2B). In
contrast, CXCR2 mRNA was not generally induced in CLD versus
control livers, confirming prior observations [34]. However,
CXCR2 expression was increased in PBC patients (Fig. 2C). These
data showed that intrahepatic expression of IL-8 and its main
receptor CXCR1 was significantly induced in chronic liver injury,
indicating that this pathway might be an important factor in
driving hepatic inflammation and disease progression.
Intrahepatic accumulation of neutrophils and
macrophages in chronic liver diseases
Neutrophils have been described as a major target of IL-8 in
inflammatory diseases [37]. To better understand the biological
relevance of IL-8 and its receptors CXCR1 and CXCR2 in CLD
we stained the liver sections for myeloperoxidase (MPO), a
common marker for activated neutrophils. Although MPO
+
neutrophils could be regularly found in livers from CLD patients
by immunohistochemistry, the clear increase of IL-8 and CXCR1
mRNA in cirrhotic samples was not associated with increased
neutrophil counts in livers with cirrhosis compared to non-
cirrhotic livers (Fig. 3A). Nevertheless, there was a distinct rise of
intrahepatic neutrophils in PBC, indicating that neutrophils might
be specifically involved in this disease entity.
Figure 1. Serum IL-8 levels in healthy controls and patients with chronic liver disease. (A) Serum IL-8 levels are significantly increased in
patients compared to healthy controls. (B) Cirrhotic patients show higher IL-8 serum levels than non-cirrhotics. (C) Dissecting the various stages of
CLD revealed that IL-8 levels are highest in end-stage liver disease. (D) Patients with underlying alcoholic and biliary/autoimmune liver diseases
showed higher IL-8 serum concentrations than viral hepatitis or other causes of CLD. (E) To normalize for the stage of cirrhosis, IL-8 serum levels were
divided by the Child-Pugh score points. Elevated IL-8 in cholestatic and alcoholic liver diseases remained significant. CLD, chronic liver disease; AIH,
autoimmune hepatitis.
doi:10.1371/journal.pone.0021381.g001
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respond to IL-8, because monocytic expression of the IL-8
receptors CXCR1 and CXCR2 can be induced by several
mediators like the Th2 cytokines IL-4 and IL-13 [38]. In fact, the
numbers of macrophages significantly increased with progression
of liver fibrosis, as evidenced by immunohistochemistry for CD68
(Fig. 3B). This finding suggested that monocytes/macrophages
might be the primary responders to IL-8 in liver diseases.
Circulating monocytes from patients with liver cirrhosis
up-regulate CXCR1 expression
Following the hypothesis that monocytes/macrophages are an
important target of elevated IL-8 in CLD, we analyzed the
expression of CXCR1 and CXCR2 by monocytes in peripheral
blood. We purified circulating monocytes from healthy controls
(n=31) and CLD patients (n=111) by CD14-labelled microbeads
at a .95% purity (Fig. 4A). CXCR1 and CXCR2 gene expression
was assessed by quantitative real-time PCR. Monocytes isolated
from patients with established cirrhosis (n=69) expressed
significantly higher CXCR1 mRNA than from non-cirrhotic
patients (n=42) (Fig. 4B). In contrast, monocytic CXCR2
expression was moderately down-regulated in patients compared
to healthy controls, independent of the presence of cirrhosis
(Fig. 4C). We confirmed these findings for a subgroup of study
participants on a protein level as well. In patients with liver
cirrhosis, monocytic CXCR1 expression was significantly upregu-
lated compared to healthy controls (Fig. 4D–F). CXCR2 was only
barely detectable on circulating monocytes from healthy volun-
teers or patients (Fig. 4D). These data demonstrated that CXCR1
is upregulated on peripheral monocytes from patients with liver
cirrhosis, corroborating that monocytes might be an important
target of IL-8 in chronic liver diseases. Furthermore, these findings
paralleled the intrahepatic expression patterns of up-regulated
CXCR1, but not CXCR2 (Fig. 2), in patients with liver cirrhosis.
Gene expression of CXCR3, the receptor for CXCL9 (MIG),
CXCL10 (IP-10) and CXCL11 (I-TAC), was only detected at very
Table 2. Correlation analysis of serum IL-8 concentrations with other laboratory parameters.
all patients (n=200) cirrhotic patients (n=123)
r p r p
Inflammation
white blood cell count 0.163 0.04 - n.s.
neutrophil count 0.155 0.034 - n.s.
C-reactive protein 0.315 ,0.001 0.268 0.003
IL-6 0.340 ,0.001 0.350 ,0.001
IL-10 0.220 0.002 0.245 0.018
IL-1b 0.267 ,0.001 0.238 0.008
IL-4 0.243 0.001 - n.s.
IL-2R 0.245 0.026 - n.s.
TNFa 0.258 ,0.001 0.342 ,0.001
IFNy 0.241 0.003 0.345 0.001
Chemokines
MCP-1 (CCL2) 0.345 ,0.001 0.308 ,0.001
MIP-1a (CCL3) 0.344 ,0.001 0.334 0.003
MIP-1b (CCL4) 0.720 ,0.001 0.734 ,0.001
MIG (CXCL9) 0.340 ,0.001 0.238 0.008
IP-10 (CXCL10) 0.357 ,0.001 - n.s.
Liver function
MELD score n.a. n.a. 0.242 0.008
Child-Pugh-score n.a. n.a. 0.321 ,0.001
albumin 20.338 ,0.001 20.213 0.020
pseudocholinesterase 20.337 ,0.001 20.235 0.011
prothrombin time 20.236 0.001 20.240 0.008
Cholestasis
bilirubin (conjugated) 0.394 ,0.001 0.368 ,0.001
gamma-glutamyl-transferase 0.308 ,0.001 0.220 0.016
alkaline phosphatase 0.402 ,0.001 0.285 0.002
Fibrosis markers
procollagen-III-peptide 0.349 ,0.001 0.397 ,0.001
hyaluronic acid 0.314 ,0.001 - n.s.
Correlations of serum interleukin-8 with other laboratory parameters were assessed by Spearman rank correlation test, and data are presented for all patients as well as
for the subgroup of patients with liver cirrhosis. Only significant (p,0.05) results are shown.
doi:10.1371/journal.pone.0021381.t002
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downregulated in CLD patients (data not shown). Thus, we could
exclude that macrophage infiltration was primarily driven by
CXCR3 ligands, which are also upregulated during liver disease
progression [39].
Proinflammatory CD16
+ monocyte-derived macrophages
are potent producers of IL-8
To this point, our data demonstrated that IL-8 expression is
induced systemically and intrahepatically in patients with CLD
and that monocytes might be important responders to IL-8 during
liver disease progression. However, macrophages have also been
described as important IL-8 producing cells [40]. We therefore
investigated whether macrophages from CLD patients may
contribute to elevated IL-8 by an increased capacity to secrete
IL-8. Macrophages from healthy volunteers (n=20) and patients
with liver cirrhosis (n=15) were obtained by isolating peripheral
monocytes and subsequent culture of adherent cells with
autologous serum for 48 h. Macrophages from cirrhotic patients
showed a significantly higher IL-8 synthesis in vitro (Fig. 5A). Of
note, the production of other cytokines or chemokines like MCP-1,
IL-10, IL-6, TNFa, MIP-1a, MIP-1b and IL-1b did not differ
between patients and controls [4]. Also in contrast to other
inflammatory cytokines, IL-8 production by monocyte-derived
macrophages could not be further stimulated by LPS (Fig. 5A).
We had previously reported that ‘non-classical’ CD14
+CD16
+
monocytes, in contrast to ‘classical’ CD14
++CD16
2 monocytes,
are critically involved in liver fibrosis progression in humans, by
perpetuating a pro-inflammatory hepatic cytokine microenviron-
ment and directly activating collagen-producing hepatic stellate
cells [4]. Thus, we also compared these two major monocyte
subsets for their IL-8 secretion capacity. In line with their
described pro-inflammatory phenotype [31], CD14
+CD16
+
monocytes secreted significantly higher amounts of IL-8 in vitro
compared to CD14
++CD16
2 monocytes upon LPS stimulation
(Fig. 5B). Interestingly, this difference did not reach statistical
significance without LPS stimulation, suggesting that endotox-
Figure 2. Intrahepatic IL-8 and IL-8 receptor gene expression. Gene expression levels of IL-8 (A) and the IL-8 receptors CXCR1 (B) and CXCR2
(C) were assessed from liver tissue by real-time qPCR and are displayed as fold induction. Samples from CLD patients were divided according to
fibrosis stage (middle graphs) and to disease etiology (right graphs). Tissue from acute liver failure (ALF) was analyzed in parallel for comparison. CLD,
chronic liver disease; ctrl, control; PBC, primary biliary cirrhosis; ALD, alcoholic liver disease; ALF, acute liver failure.
doi:10.1371/journal.pone.0021381.g002
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monocytic IL-8 secretion. Both monocyte subtypes were much
more potent to synthesize IL-8 than lymphocytes (T-, B- and NK-
cells) that were cultured as control cells (Fig. 5B). Taken together,
these experiments revealed that monocytes not only respond to IL-
8 in liver disease, but are also potent producers of IL-8. This
indicates that IL-8, especially from ‘non-classical’ CD14
+CD16
+
monocytes, might contribute to amplify inflammatory signals in
liver fibrosis.
Discussion
The CXC chemokine IL-8 (CXCL8) has long been identified as
a major factor of acute inflammation, acting as a potent
chemoattractant and activator of neutrophils by two receptors,
CXCR1 and CXCR2 [37]. High IL-8 levels in the liver and the
circulation have been found in patients with acute liver injury,
such as alcoholic hepatitis or ischemia-reperfusion injury
[9,10,42]. While these conditions are clearly associated with
neutrophil-mediated tissue damage [15], less data exist about the
involvement of IL-8 and/or neutrophils in chronic liver injury. By
comprehensively analyzing a large cohort of patients with various
liver diseases, we here show that serum IL-8 levels were
significantly elevated in CLD patients. IL-8 serum levels were
closely associated with the progression of fibrosis/cirrhosis, as
reflected by clinical scores (e.g. Child-Pugh, MELD) and
laboratory tests indicating deteriorated liver function or progressed
fibrosis. Thus, our data expand prior studies that were restricted to
patients with HCV infection or alcoholic disease [24,25,26].
Moreover, our data implicate that the source of elevated
circulating IL-8 in patients with chronic liver diseases is likely
the injured liver, because intrahepatic IL-8 gene expression was
strongly (about 12-fold) induced in patient in comparison to
control tissue.
Besides the clear association of IL-8 with disease progression, we
noticed distinct differences in IL-8 serum and intrahepatic
expression dependent on the underlying disease etiology. Patients
with alcoholic, but surprisingly also with cholestatic liver diseases
had highest IL-8 levels. Interestingly, hepatic IL-8 expression was
exceptionally high in patients with PBC. In line, IL-8 expression
had been previously detected specifically in injured biliary
epithelial cells in patients with cholestatic liver diseases and linked
to neutrophilic infiltration around reactive bile ducts [35]. Such a
specific chemoattractive role of IL-8 for neutrophil infiltration to
Figure 3. Immunohistochemical analysis of neutrophil and macrophage accumulation in chronic liver disease. (A) Myeloperoxidase
(MPO) staining was performed to detect neutrophils within the liver. Upper panels depict representative images of neutrophil accumulation in PBC
(left column) and HCV (right column) with F4 fibrosis at 2006 magnification, lower panels magnify the periportal region of upper panels. MPO-
positive neutrophils accumulate in PBC in comparison to ALD, HCV and HBV, whereas degree of fibrosis was not indicative for neutrophil count
within the liver. Neutrophil cell infiltrate predominate within the cirrhotic fibres in periportal regions whereas remaining parenchyma was absent for
neutrophil invasion. (B) CD68
+ cells indicating macrophages accumulate according to severity of liver disease irrespective of underlying etiology.
Images represent exemplarily distribution of CD68
+ in F0 fibrosis (AIH) and F4 fibrosis (PBC). Scale bars represent 100 mm. AIH, autoimmune hepatitis;
PBC, primary biliary cirrhosis; ALD, alcoholic liver disease.
doi:10.1371/journal.pone.0021381.g003
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would also fit to the prominent accumulation of MPO
+ neutrophils
that we noticed in livers of PBC patients.
On the other hand, the high IL-8 expression in non-biliary
cirrhosis could not be attributed to a clear hepatic neutrophil
accumulation in progressing fibrosis per se. In fact, we observed
that fibrosis progression was paralleled by increasing intrahepatic
CXCR1 levels and increasing CD68
+ hepatic macrophages. This
indicated that monocytes/macrophages might be the main IL-8
responding cells in chronic liver disease patients. It has been
reported previously that the Th2-cytokines IL-4 and IL-13
promote the up-regulation of CXCR1 and CXCR2 on human
monocytes, thereby ‘converting’ IL-8 and related ELR
+ chemo-
kines, prototypic neutrophil attractants, into monocyte chemotac-
Figure 4. CXCR1 and CXCR2 mRNA and protein expression on circulating monocytes. (A) Monocytes were purified from whole blood by
MACS with anti-CD14 antibodies, revealing purities above 95%. Representative FACS analysis before and after purification is shown. (B–C) Gene
expression levels of the IL-8 receptors CXCR1 (B) and CXCR2 (C) were assessed from purified circulating monocytes of patients and controls and are
displayed as relative expression levels. CLD, chronic liver disease. (D) CXCR1 and CXCR2 expression was also measured on a protein level by FACS.
Representative plots from a healthy control (left) and patients with alcoholic Child C cirrhosis (right) are shown; pre-gating on CD14
+ monocytes to
exclude CXCR1 expression by neutrophils. (E) Representative histograms showing how mean fluorescence intensity (MFI) was assessed: isotype
control staining was subtracted from CXCR1 expression on circulating CD14
+ monocytes from healthy controls or patients. (F) Comparison of
monocytic CXCR1 protein expression between healthy controls and patients with liver cirrhosis. Peripheral blood neutrophils served as a positive
control for CXCR1 and CXCR2 staining (not shown).
doi:10.1371/journal.pone.0021381.g004
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cirrhotic patients indeed had increased CXCR1 expression, both
on a gene and protein level. The enhanced monocytic CXCR1
expression could likely result from induction by Th2-cytokines,
because IL-4 was found increase with progression of liver disease
(not shown) and to correlate with serum IL-8 in our cohort
(Table 2). These findings are in line with the current concept that
advanced fibrotic disorders are generally characterized by strong
Th2-biased immune responses [43].
Although our data demonstrate an association between IL-8
expression, macrophage infiltration and disease progression in
patients with liver cirrhosis, the direct functional role of IL-8 in
human liver disease is difficult to dissect. Functional experimental
approaches with animal models are limited, because mice do not
bear an IL-8 encoding gene, but only express the gene gro, whose
gene product is the chemokine CXCL1/KC. Murine CXCL1
shows only 68% sequence identity with the human CXCL1. These
differences between species are certainly a main reason why it is
difficult to further dissect the role of this ELR
+ chemokine in liver
inflammation [44]. However, in vitro experiments characterized
CXCR1
+ macrophages as polarized towards the alternatively
activated M2 macrophage phenotype [38], which is believed to act
pro-fibrogenic in hepatic fibrosis [45]. Interestingly, IL-8 secreted
by injured hepatocytes was shown to activate collagen-producing
hepatic stellate cells in vitro [27]. Our study expands the
profibrogenic potential of IL-8 by showing that the IL-8 signal is
also amplified by ‘non-classical’, fibrosis-associated CD16
+ mono-
cytes/macrophages [4] and that IL-8 is in chronically inflamed
liver directly associated with the number of hepatic macrophages,
rather than hepatic neutrophils. Thus, our data support that IL-8
contributes to establish a profibrogenic microenvironment in
chronic liver diseases and propose a novel role of IL-8 for the
recruitment and activation of hepatic macrophages in human liver
cirrhosis.
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